MS S, Manjunath, PL B, KN R, Mukesh. A Prospective Randomised Open Label Study to Evaluate the Response Rate and Toxicity of Gefitinib in the Treatment of Carcinoma Cervix Patients on Chemoradiotherapy. J. Clin. Res. App. Med. [Internet]. 2022 Feb. 5 [cited 2024 Nov. 23];1(2):59-62. Available from: https://jcramonline.com/index.php/jcram/article/view/14